Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 204-694-8
CAS number: 124-28-7
Male and female CD-1 mice were exposed dermal against 0, 0.05, 0.13 or
0.26 % test substance for 104 wk. This corresponds to an average daily
doses of 0, 1.1, 2.8 or 5.6 mg/kg bw/day. There
were no statistical differences in group average body weights, organ
weights, and organ to body weight ratios among treated animals compared
to controls. Compound related No skin tumors were observed in any group.
There were no compound-related skin or systemic neoplasms in the study.
The NOAEL for chronic repeated dose toxicity after dermal application in
mice is >= 0.26 % (5.6 mg/kg bw/day).
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
Welcome to the ECHA website. This site is not fully supported in Internet Explorer 7 (and earlier versions). Please upgrade your Internet Explorer to a newer version.
Do not show this message again